Purpose: Two PHEA self-assembling derivatives were developed for parenteral administration of rh-GH. Results: PHEA-C16 and PHEA-PEG5-C16 yielded 12.1\ub11.3% and 8.5\ub10.4% protein/polymer (w/w) loading, respectively. The Scatchard and Klotz analysis showed that rh-GH associates more tightly and is released more slowly from PHEA-C16 as compared to PHEA-PEG5-C16. In vivo, the polymer association prolonged the drug absorption (tmax) and increased the bioavailability (AUC) as compared to the free protein. The protein bioavailability obtained with PHEA-PEG5-C16 was higher than that obtained with PHEA-C16 and increased as the protein/polymer ratio increased. Conclusions: amphiphilic PHEAs can be successfully exploited to yield sustained pro...
A novel system for delivering recombinant human growth hormone (rhGH) that is noninvasive and has a ...
The overall goal of this research is to prepare amphiphilic poly(monomethoxypolyethylene glycol-co-D...
Human growth hormone (hGH) suffers from a short plasma half-life of similar to 15 min, necessitating...
The protein delivery properties of polymer supramolecular assemblies were investigated by using reco...
Methoxy-poly(ethylene glycol)s bearing a terminal cholanic moiety (mPEG5kDa-cholane, mPEG10kDa-chola...
An effective and safe formulation of sustained-release rhGH for two months using poly(monomethoxypol...
An effective and safe formulation of sustained-release rhGH for two months using poly(monomethoxypol...
Protein therapeutics have tremendous potential to treat a variety of debilitating diseases, however,...
In order to overcome the biological deficiencies of synthetic polymers and to enhance the mechanical...
The delivery of therapeutic proteins has gained momentum with development of biotechnology. However,...
The application of atom transfer radical polymerization (ATRP) for preparation of a novel class of p...
Gonadotropin-releasing hormone (GnRH) agonists are peptides consisting of nine or ten amino acid res...
A novel sustained release formulation of recombinant human growth hormone (SR-rhGH) was developed as...
The application of atom transfer radical polymerization (ATRP) for preparation of a novel class of p...
AbstractObjectiveIncorporate recombinant human growth hormone in a biodegradable polymer (PLGA).Mate...
A novel system for delivering recombinant human growth hormone (rhGH) that is noninvasive and has a ...
The overall goal of this research is to prepare amphiphilic poly(monomethoxypolyethylene glycol-co-D...
Human growth hormone (hGH) suffers from a short plasma half-life of similar to 15 min, necessitating...
The protein delivery properties of polymer supramolecular assemblies were investigated by using reco...
Methoxy-poly(ethylene glycol)s bearing a terminal cholanic moiety (mPEG5kDa-cholane, mPEG10kDa-chola...
An effective and safe formulation of sustained-release rhGH for two months using poly(monomethoxypol...
An effective and safe formulation of sustained-release rhGH for two months using poly(monomethoxypol...
Protein therapeutics have tremendous potential to treat a variety of debilitating diseases, however,...
In order to overcome the biological deficiencies of synthetic polymers and to enhance the mechanical...
The delivery of therapeutic proteins has gained momentum with development of biotechnology. However,...
The application of atom transfer radical polymerization (ATRP) for preparation of a novel class of p...
Gonadotropin-releasing hormone (GnRH) agonists are peptides consisting of nine or ten amino acid res...
A novel sustained release formulation of recombinant human growth hormone (SR-rhGH) was developed as...
The application of atom transfer radical polymerization (ATRP) for preparation of a novel class of p...
AbstractObjectiveIncorporate recombinant human growth hormone in a biodegradable polymer (PLGA).Mate...
A novel system for delivering recombinant human growth hormone (rhGH) that is noninvasive and has a ...
The overall goal of this research is to prepare amphiphilic poly(monomethoxypolyethylene glycol-co-D...
Human growth hormone (hGH) suffers from a short plasma half-life of similar to 15 min, necessitating...